Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REFOCUS: Refined Fecal Microbiota Transplantation (FMT) Delivered by Oral Capsules for Induction of Remission in Mild to Moderate Ulcerative Colitis - a Phase I Study

NCT04968951 is registered in ClinicalTrials.gov with Ari M Grinspan as lead sponsor.

NCT NCT04968951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04968951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REFOCUS: Refined Fecal Microbiota Transplantation (FMT) Delivered by Oral Capsules for Induction of Remission in Mild to Moderate Ulcerative Colitis - a Phase I Study
Lead sponsor
Ari M Grinspan
Phase
Phase 1
Overall status
Terminated
Start date
November 10, 2021
Completion date
August 22, 2022
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fecal microbiota transplant, fmt, ulcerative colitis